participating faculty
PARTICIPATING FACULTY The Great Debate: Consensus Guidelines or Specialist Discretion for Managing Specialty Pharmaceuticals? This supplement to The American Journal of Managed Care includes information on the pros and cons of using consensus treatment guidelines to manage specialty pharmaceuticals in managed care organizations.
Faculty John D. Golenski, EdD Executive Director The Institute for Ethics & Health Policy Berkeley, California
Mark Zitter, MBA Chief Executive Officer The Zitter Group Millburn, New Jersey
Sean D. Sullivan, PhD Professor School of Pharmacy and School of Public Health and Community Medicine University of Washington Seattle, Washington
Disclosure Statement It is the policy of ACCESS Medical Group Department of Continuing Education and Medical Outcomes Management, Inc to ensure balance, independence, objectivity, and scientific rigor in all their sponsored or jointly sponsored educational programs. The information presented in this monograph represents the views and opinions of the participating faculty and does not represent those of ACCESS Medical Group Department of Medical Education, Medical Outcomes Management, Inc, Genentech, Novartis, or any manufacturers mentioned herein. The publication may include the discussion of products for indications not approved by the FDA. Participants are encouraged to consult package inserts for updated prescribing information. It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. The following participants have declared no financial affiliations with corporate organizations: ■ John D. Golenski, EdD ■ Sean D. Sullivan, PhD
This participant has declared the following affiliations with corporate organizations: ■ Mark Zitter, MBA Consultant For: Abbott Laboratories Amgen Bayer Berlex Laboratories Biogen Idec, Inc Centocor Genentech Roche Laboratories Teva Neurosciences
Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.
S230
THE AMERICAN JOURNAL OF MANAGED CARE
AUGUST 2004
Faculty John D. Golenski, EdD Executive Director The Institute for Ethics & Health Policy Berkeley, California
Mark Zitter, MBA Chief Executive Officer The Zitter Group Millburn, New Jersey
Sean D. Sullivan, PhD Professor School of Pharmacy and School of Public Health and Community Medicine University of Washington Seattle, Washington
Disclosure Statement It is the policy of ACCESS Medical Group Department of Continuing Education and Medical Outcomes Management, Inc to ensure balance, independence, objectivity, and scientific rigor in all their sponsored or jointly sponsored educational programs. The information presented in this monograph represents the views and opinions of the participating faculty and does not represent those of ACCESS Medical Group Department of Medical Education, Medical Outcomes Management, Inc, Genentech, Novartis, or any manufacturers mentioned herein. The publication may include the discussion of products for indications not approved by the FDA. Participants are encouraged to consult package inserts for updated prescribing information. It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. The following participants have declared no financial affiliations with corporate organizations: ■ John D. Golenski, EdD ■ Sean D. Sullivan, PhD
This participant has declared the following affiliations with corporate organizations: ■ Mark Zitter, MBA Consultant For: Abbott Laboratories Amgen Bayer Berlex Laboratories Biogen Idec, Inc Centocor Genentech Roche Laboratories Teva Neurosciences
Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.
S230
THE AMERICAN JOURNAL OF MANAGED CARE
AUGUST 2004
